¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ°£¾ÏÇÐȸ ILCA School of Liver Cancer : 2024-04-06

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇÑ°£¾ÏÇÐȸ ILCA School of Liver Cancer : 2024-04-06
±³À°ÀÏÀÚ : 2024-04-06
±³À°Àå¼Ò : ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀǽÇ

±³À°ÁÖÁ¦ : ILCA School of Liver Cancer

ÁÖÃÖ±â°ü : ´ëÇÑ°£¾ÏÇÐȸ
´ã´çÀÚ : ¿ÀÀ±Àç ´ë¸®
¿¬¶ôó : 02-373-1005  

À̸ÞÀÏ : klca@hbni.co.kr

±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, º´¸®°ú

Âü¼®¿¹»óÀÎ : 70¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 40ºÐ

¼¼ºÎ¼ö°­·á : 300,000¿ø  

ºñ°í ILCA member 200,000¿ø / Non member 300,000¿ø / Resident, Fellow, Trainee, Researcher 70,000¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 08:40~08:55 Exploring Tumor Microenvironment and Immunology in HCC Pil Soo Sung(The Catholic Univ. of Korea)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 08:55~09:10 The Oncogenomic Landscape in HCC Sun Young Yim(Korea Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 09:10~09:25 Pathological and Molecular Features of HCC and CCC Haeryoung Kim (Seoul National Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 09:25~09:40 Molecular Features and Classification of ICC and Combined HCC-CCC Hyun Goo Woo (Ajou Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 09:40~10:00 Meet the Professor and Speaker (Discussion with Q&A) Jessica Zucman-Rossi, Joong-Won Park, Young Nyun Park, Moon Seok Choi(Univ. Paris Descartes, France, Myongji Hospital, Hanyang Univ. , Yonsei Univ., Sungkyunkwan Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 10:00~10:15 What is the Best Option for Advanced HCC?: Second-Line and Sequential Therapy  Bo Hyun Kim(National Cancer Center)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 10:15~10:30 Can We Predict Treatment Response in the Era of Immuno-Oncology? Do Young Kim (Yonsei Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 10:30~10:45 How to Expect and Manage the Adverse Events of Immunotherapy? Wonseok Kang (Sungkyunkwan Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 10:45~11:00 How to Boost TKI Efficacy in Advanced HCC with Combination Therapies Ju Hyun Shim (Univ. of Ulsan)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 11:00~11:20 Meet the Professor and Speaker (Discussion with Q&A) Tim Meyer, Jong Young Choi, Lorenza Rimassa, Ho Yeong Lim(Univ. College London, UK, The Catholic Univ. of Korea, Humanitas Univ., Italy,  Sungkyunkwan Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 11:40~11:55 What are the Current and Future Trends in Imaging Diagnosis of HCC? So Yeon Kim(Univ. of Ulsan)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 11:55~12:10 Imaging-Based Prediction of Prognosis for HCC Seung Baek Hong (Pusan National Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 12:10~12:25 Surveillance and Post-Treatment Response Evaluation Eun Sun Jang (Seoul National Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 12:25~12:40 Optimal Medical Care to Improve Outcomes after HCC Treatment Sung Won Lee (The Catholic Univ. of Korea)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 13:40~13:55 Evolving Role of TACE in the Intermediate-Stage HCC: Good or Poor Responders? Dongho Hyun(Sungkyunkwan Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 13:55~14:10 Transarterial Radioembolization for HCC: Patient Selection and Assessment Hyo-Cheol Kim (Seoul National Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 14:10~14:25 Evolution of Radiotherapy for HCC: Balancing Tumor Control and Hepatic Function Preservation Sang Min Yoon(Univ. of Ulsan)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 14:25~14:40 Particle Beam Radiotherapy: Best Indications for HCC Tae Hyun Kim(National Cancer Center)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 14:40~14:55 Minimally Invasive Liver Resection for HCC and CCC Dong-Sik Kim(Korea Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 14:55~15:10 Liver Transplantation in HCC and CCC: Expanding Indications Dong Jin Joo (Yonsei Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 15:10~15:25 Clinical Decision in Borderline Lesions for Local Ablation Therapy Dong Ho Lee (Seoul National Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 15:25~15:40 Role of Local Ablation Therapy as a Bridge for Curative Therapy Joon-Il Choi (The Catholic Univ. of Korea)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 16:00~16:20 HCC with Intermediate Stage Jung Hee Kim (Hallym Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 16:20~16:40 HCC with Vascular Invasion Young-Sun Lee (Korea Univ.)

±³À°½Ã°£ 04¿ù 06ÀÏ ¼­¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°­ÀÇ½Ç 16:40~17:00 HCC with Metastasis Sangyoun Hwang(Dongnam Inst. of Radiological £¦ Medical Sciences)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ°£¾ÏÇÐȸ ILCA School of Liver Cancer : 2024-04-06""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2024³â ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦ 37Â÷ º½ Çмú´ëȸ(2ÀÏÂ÷) : 2024-04-06
´ÙÀ½±Û ÇѾç´ëÇб³º´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-04-06
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
60 ºÎ»ê 2018³â ´ëÇѼÒÈ­±â¿¬°üÇÐȸ ºÎ¿ï°æÁöȸ ¿¬¼ö°­Á : 2018-08-18 0 675 2018-07-28
59 ¼­¿ï ´ëÇÑ»êºÎÀΰúÀÇ»çȸ&Çѱ¹¹ß»ý»ý¹°ÇÐȸ Joint Symposium : 2018-08-18 0 1,080 2018-07-28
58 ¼­¿ï ´ëÇѺ´¸®ÇÐȸ 8th Ç÷¾×º´¸® ¿¬¼ö±³À° : 2018-08-18 0 706 2018-07-28
57 ¼­¿ï ´ëÇѴٹ߼º°æÈ­ÁõÇÐȸ 2018³â ¿¬·ÊÇмú´ëȸ : 2018-08-18 0 835 2018-07-28
56 ¼­¿ï ´ëÇÑÀ̺ñÀÎÈÄ°úÇÐȸ 2018³âµµ Á¦2Â÷ ÁöµµÀü¹®ÀÇ ±³À° : 2018-08-17 0 857 2018-07-28
55 °­¿ø ´ëÇѽÉÀåÇÐȸ Ç÷°ü¿¬±¸È¸ ÇÏ°è½ÉÆ÷Áö¾ö : 2018-08-17 0 1,286 2018-07-28
54 ¼­¿ï Á߾Ӵ뺴¿ø »êºÎÀΰú žÆÃÊÀ½ÆÄ ¿¬¼Ó°­Á : 2018-08-16 0 659 2018-07-28
53 ¼­¿ï °Ç±¹´ëÇб³º´¿ø À̺ñÀÎÈÄ°ú °³¿øÀÇ ¿¬¼ö±³À°(ÈĵÎÁúȯ) : 2018-08-16 0 728 2018-07-28
52 ¼­¿ï ´ëÇÑÀÇ»çÇùȸ [Á¦27±â ÀÇ·áÁ¤Ã¥ÃÖ°íÀ§°úÁ¤] °Ç°­º¸Çè ¼ö°¡°áÁ¤ : 2018-08-16 0 865 2018-07-28
51 ¼­¿ï Çѱ¹¿ªÇÐȸ Biomarker ¸¦ ÀÌ¿ëÇÑ ¿¬±¸ ¼³°è¿Í ºÐ¼® : 2018-08-14 0 1,277 2018-07-28
50 ¼­¿ï Á¦240ȸ ´ëÇÑ ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸ ¿ù·Ê ÇмúÁý´ãȸ : 2018-08-14 0 423 2018-07-28
49 ¼­¿ï Çѱ¹¿ªÇÐȸ MR ±â¹Ý À¯Àüü ¿ªÇבּ¸¿Í °ø°ø°Ç°­ÀÚ·á ±â¹Ý Outcome research : 2018-08-13 0 646 2018-07-28
48 ¼­¿ï °¡Å縯´ëÇб³¼­¿ï¼º¸ðº´¿ø 2018 Catholic Orthopedic Symposium II - Foot & Ankle, Hip, Knee - : 2018-08-12 0 1,100 2018-07-28
47 ¼­¿ï 2018 ´ëÇÑÈäºÎ¿µ»óÀÇÇÐȸ ¿¬¼ö°­Á : 2018-08-12 0 539 2018-07-28
46 ¼­¿ï 2018 Á¦ 2ȸ ´ëÇѺ¹¸·¾ÏÇÐȸ ±¹Á¦½ÉÆ÷Áö¾ö : 2018-08-11 0 1,421 2018-07-28
1401 | 1402 | 1403 | 1404 | 1405 | 1406 | 1407 | 1408 | 1409
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷